8E7-29110-39318
4 vaccinations
11 coded responses
45 check-ins
11 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 302 / GA
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Pfizer-BioNTech
- 2021-01-14
-
2021-01-15
Survey response — days 1–6 daily, dose 1MedDRA: Diverticulum, Flatulence — Feeling: Good · Site: Pain, SwellingFree text: May have been diverticula but had major gas and flatulence last night.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-16
- 2021-01-17
- 2021-01-18
-
2021-01-21
Survey response — day 7, dose 1MedDRA: Lymph node pain — Feeling: GoodFree text: Lymph nodes under injection arm are slightly tender (not swelled)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-28
-
2021-02-04
Dose 2 — Pfizer-BioNTech
- 2021-02-04
- 2021-02-05
-
2021-02-06
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: PainFree text: Lymph node under injection arm slightly puffed and tender.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-07
- 2021-02-08
- 2021-02-10
-
2021-02-11
Survey response — day 7, dose 2MedDRA: Lymph node pain — Feeling: GoodFree text: Lymph nodes under injection arm slightly tender in early morning but gone by afternoon.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
-
2021-03-18
Survey response — day 42, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Lymph nodes under left injection arm have been extra tender.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-06
Survey response — 3 months, dose 2MedDRA: Lymph node pain — Feeling: GoodFree text: Lymph nodes became tender again.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-05
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Urinary tract infection — Feeling: Poor · Fever · Chills · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: UTI requiring antibiotics.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Urinary tract disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Discomfort urinatingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Urinary tract discomfort — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Discomfort when urinatingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Dysuria — Feeling: Fair · Be unable to work or attend schoolFree text: Discomfort urinatingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — day 7, dose 3MedDRA: Urinary tract disorder — Feeling: GoodFree text: Mild discomfort urinatingMedDRA releases: 2024-11 · check-in free text available
- 2021-10-07
- 2021-10-11
-
2021-10-12
Call successfulDoes not wish to fill out VAERS report
- 2021-10-18
- 2021-10-25
- 2021-11-03
- 2021-11-08
- 2021-12-27
- 2022-03-28
-
2022-04-11
Dose 4 — Pfizer-BioNTech
- 2022-04-15
- 2022-04-16
- 2022-04-17
- 2022-04-18
- 2022-04-25
- 2022-05-02
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-07-11
- 2022-10-12
- 2023-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-04-11 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): May have been diverticula but had major gas and flatulence last night.
Release 2 — day 7, dose 1
Systemic reaction (other): Lymph nodes under injection arm are slightly tender (not swelled)
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Lymph node under injection arm slightly puffed and tender.
Release 4 — day 7, dose 2
Systemic reaction (other): Lymph nodes under injection arm slightly tender in early morning but gone by afternoon.
Release 5 — day 42, dose 2
Symptoms: Lymph nodes under left injection arm have been extra tender.
Release 8 — 3 months, dose 2
Symptoms: Lymph nodes became tender again.
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): UTI requiring antibiotics.
Systemic reaction (other): Discomfort urinating
Systemic reaction (other): Discomfort when urinating
Systemic reaction (other): Discomfort urinating
Release 10 — day 7, dose 3
Systemic reaction (other): Mild discomfort urinating
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Lymph node pain | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Diverticulum | ✓ | ✓ | ✓ |
| SRO | Dysuria | · | · | ✓ |
| SRO | Flatulence | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Urinary tract discomfort | · | · | ✓ |
| SRO | Urinary tract disorder | · | · | ✓ |
| SRO | Urinary tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release